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Abstract In preparations of cartilage oligomerie matrix protein 
(COMP) from bovine tendon two contaminating polypeptides of 
120 and 135 kDa were detected. N-Terminal protein sequencing 
of these polypeptides showed homology to the N-terminus and to 
an internal sequence in TSP-4, respectively. TSP-4 was further 
enriched by heparin affinity chromatography. Electron micros- 
copy of this sample shows primarily five armed particles with 
globular domains at the periphery connected to a central assem- 
bly domain in which smaller N-terminal globular domains can be 
resolved tightly packed at the center of the particle. We can 
thereby confirm the pentameric model for TSP-4 proposed by 
Lawler et al. [(1995) J. Biol. Chem. 270, 2809-2814], on the basis 
of recombinantly expressed protein. We further show that TSP-4 
is abundant in tendon. 
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I. Introduction 
The thrombospondins (TSP) form a protein family including 
the originally studied TSP-1 as well as TSP-2 [2], TSP-3 [3], 
TSP-4 [4] and COMP [5,6,7]. A structural model for the proto- 
type thrombospondin, TSP-1, was postulated on the basis of 
sequence interpretation [8] and molecular electron microscopy 
[9]. Each subunit of Mr 127,500 has an N-terminal and a C- 
terminal globular domain connected by a region of more ex- 
tended structure. Close to the N-terminal globular domain di- 
sulfide bonds connect he subunits to a trimeric structure. The 
sequence of the major extended portion is made up of stretches 
of so called TSP type I, type II and type III repeats, in order 
from the N- to the C-terminus. The type I repeats hare homol- 
ogy with a variety of proteins whereas the type II repeats are 
homologous to epidermal growth factor (EGF). The type III 
repeats are more unique to the thrombospondin family and are 
considered to be the Ca 2+ binding structure in thrombospondin. 
The larger C-terminal globular domain does not show sequence 
similarity with any protein outside the thrombospondin family. 
TSP-2 shows extensive sequence homology with TSP-1 [2], has 
a very similar domain structure and also forms trimers [10]. The 
partial sequence known for TSP-3 does not yet allow for predic- 
tion of its molecular structure. The sequence for TSP-4 for 
Xenopus laevis [4] and for man [1,11] has been completed, and 
shows that this variant lacks the type I repeats. Recombinantly 
expressed TSP-4 molecules were recently prepared and shown 
by electron microscopy to form pentamers imilar to COMP 
[1]. TSP-4 contains a N-terminal globular domain of about 
200 amino acids which has been implicated in heparin bind- 
ing. 
2. Materials and methods 
Fresh tendons (280 g wet weight) from adult bovine shoulder joints 
were obtained from the local slaughterhouse and cut into cubes of 
about 1 cm 3, homogenized five times for 10 s each using a Polytron 
homogenizer at full speed in 1000 ml of prechilled 0.15 M NaC1, 0.05 
M Tris/HC1, pH 7.4 (TBS), containing 1mM PMSF and 2 mM NEM. 
Tissue residue was collected by centrifugation at 17,700 x g at 4°C for 
20 min. This wash cycle was repeated twice, each time with 15 min of 
stirring at 4°C. The tissue residue was then suspended in 1000 ml of the 
same buffer containing, in addition, 10 mM EDTA and extracted for 
15 h with stirring at 4°C. The extraction with the EDTA-containing 
buffer was repeated once. The first EDTA extract was diluted with an 
equal volume of cold distilled water and applied to a column (35 x 2.6 
cm) of DEAE-Sepharose Fast Flow (Pharmacia) equilibrated in 0.05 
M Tris-HC1, pH 7.4, containing 1mM PMSF, 2 mM NEM, and 5 mM 
EDTA. This and all further purification steps were performed at 4°C. 
The bound proteins were eluted with a linear gradient (500+500 ml) of 
0.075 M to 0.50 M NaC1 at a flow rate of 60 ml/h. The proteins of 
interest were detected by SDS-polyacrylamide g l electrophoresis in 
fractions eluting between 0.15 and 0.20 M NaCI. The pool containing 
the 120 kDa and 135 kDa polypeptides was concentrated byultrafiltra- 
tion (Amicon YM 10 membrane) to 40 ml, divided into two parts that 
were separately applied to a column (90 x 2.6 cm) of Sepharose CL4B 
(Pharmacia) eluted with 0.25 M NaC1, 0.05 M Tris/HC1, pH 7.4, 2 mM 
PMSF, 2 mM NEM, and 10 mM EDTA at a flow rate of 40 ml/h. 
Fractions containing the proteins of interest were pooled, dialyzed 
against TBS, containing 2 mM NEM, 2 mM PMSF, and 10 mM 
EDTA, and applied to a column (15 × 2.6 cm) of heparin Sepharose 
equilibrated in the dialysis buffer. After washing, the bound proteins 
were eluted with 0.5 M NaC1, 50 mM Tris-HCl, pH 7.4, and the 
fractions enriched in the 135 kDa protein were pooled, aliquoted and 
stored at - 30°C. 
SDS-polyacrylamide g lelectrophoresis was performed according to 
the method of Laemmli [12] on gradient gels of 4-15% polyacrylamide. 
The samples were, when desired, reduced with 2.5% (v/v) 2-mercap- 
toethanol in sample buffer. Sample proteins and molar mass standards 
were detected by staining with Coomassie Brilliant Blue R. The relative 
intensity of bands was determined from scans (NIH Image) of video 
images of the gels. 
The 120 kDa and the 135 kDa proteins from bovine tendon were 
subjected to SDS-polyacrylamide g l electrophoresis after reduction 
and electroblotted to a Problott PVDF-membrane (Applied Biosys- 
tems). The membrane was briefly stained with Coomassie Brilliant Blue 
R and destained in 40% (v/v) HPLC-grade methanol. The bands of 
interest were cut out and N-terminal amino acid sequence was obtained 
using an Applied Biosystems gas phase sequenator. 
For electron microscopy, samples were dialyzed against 0.2 M am- 
monium hydrogen carbonate, pH 7.8, and diluted with an equal volume 
of 80% glycerol, sprayed onto mica and rotary-shadowed [13]. 
3. Results and discussion 
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Fig. 1. SDS-polyacrylamide g l electrophoresis of the COMP/TSP-4 
sample prior to the heparin Sepharose chromatography (a,b) and of 
unbound (c) and bound (d) pools after affinity chromatography on 
heparin Sepharose. The sample in (a) was not reduced while those in 
(b~t) were treated with 2-mercaptoethanol. The partially purified sam- 
ple from bovine tendon, containing the 120 kDa and 135 kDa polypep- 
tides and COMP as a major contaminant, was applied to heparin 
Sepharose. The unbound fraction (c) predominantly contains the 120 
kDa polypeptide and COMP. The bound fraction (d), eluted with 0.5 
M NaCI, enriched in the 135 kDa protein, contains only small amounts 
of the 120 kDa polypeptide and to a lesser amount COMP. Other 
contaminants are likely to be collagens type XII and/or XIV as ob- 
served by electron microscopy. 
selective extraction with EDTA-containing buffer, ion ex- 
change chromatography on DEAE-Sepharose, and molecular 
sieve chromatography on Sepharose CL4B [14]. On close anal- 
ysis, the preparations showed two additional bands in SDS- 
polyacrylamide g l electrophoresis that under reducing condi- 
tions migrated with an apparant molar mass of 120 and 135 
kDa, respectively (Fig. lb). Under non-reducing conditions all 
proteins migrated close to COMP (524 kDa, [6]). There ap- 
peared to be more of the 120 and 135 kDa proteins using this 
purification scheme from shoulder as compared to the earlier 
used tendons which cross the fetlock joints [14]. The selective 
extraction with EDTA-containing buffer points towards adiva- 
lent cation-dependent a chorage of the 120 and 135 kDa pol- 
ypeptides and COMP within the extracellular matrix of tendon. 
The bulk of the COMP was removed by affinity chromatogra- 
phy on heparin Sepharose, where the 135 kDa polypeptide 
bound and COMP, which lacks a heparin binding domain, 
elutes in the flow-through (Fig. lc,d). The 120 kDa polypeptide 
which had copurified with COMP and the 135 kDa protein 
(Fig. 1), also eluted in the flow-through on heparin Sepharose 
(Fig. 1). 
N-terminal sequencing of the 120 and 135 kDa proteins re- 
vealed both to be derived from TSP-4 (Fig. 2), which has been 
sequenced from Xenopus laevis [4] and man [1,11]. The 135 kDa 
protein corresponds to the full-length TSP-4 with a cleavage 
site for the signal peptide at Ala 3 (Fig. 2) when compared to the 
sequence and the predicted cleavage site proposed by Lawler 
et al. [1] for human TSP-4 on the basis of cDNA sequence 
(Fig. 2). The 120 kDa protein represents a fragment of TSP-4 
cleaved between Gln 186 and Ser j87 resulting in the removal of 
the N- terminal globular domain of TSP-4 (Fig. 2). This frag- 
mentation together with the observation that the 120 kDa 
protein does not bind to heparin Sepharose implies that the he- 
parin binding site must be within the N-terminal globular do- 
main. Therefore the 120 kDa TSP-4 fragment and COMP 
can be separated from the full-length TSP-4 by heparin affinity 
chromatography. The results are in agreement with Lawler 
et al. [1] who detected a fragment in the recombinantly ex- 
pressed human TSP-4, which is recognized by antibodies to 
TSP-4, but which was removed by heparin affinity chromatog- 
raphy. 
Electron microscopy using the glycerol spraying/rotary shad- 
owing technique of the preparation enriched for full-length 
TSP-4 showed primarily pentameric particles arranged with the 
C-terminal globular domains at the periphery followed by a 
rod-like structure leading to a central assembly domain and the 
smaller N-terminal globular domains, which are tightly packed 
in the center of the molecule (Fig. 3). The domain structure of 
TSP-4 is similar to that of TSP-1, but with five subunits, instead 
of three, assembled in a manner analogous to the structure of 
COMP. Analysis of the preparation by densitometry of SDS- 
polyacrylamide g l electrophoresis revealed that about 40% of 
the protein was in either intact TSP-4 or COMP. Out of these 
40% at least three-quarters were in TSP-4. Thus most of the 
particles een by electron microscopy are TSP-4, which can in 
optimally spread particles be distinguished from COMP by 
showing globular structures at the center of the pentameric 
molecules. We can therefore confirm the in vivo relevance of 
the pentameric model proposed by Lawler et al. [1] on the basis 
of recombinantly expressed protein. The electron microscopy 
results are also supported by the similarity in migration of 
TSP-4 and COMP on SDS-polyacrylamide g l electrophoresis 
both before (Fig. la) and after (Fig. lb) thiol reduction. 
In this study we describe for the first time the isolation of 
TSP-4 from tissue. In bovine shoulder tendon it is expressed as 
a pentameric molecule and can be highly enriched under native 
conditions by selective extraction with EDTA-containing 
buffer, ion exchange chromatography, molecular sieve chroma- 
tography, and finally affinity chromatography on heparin 
Sepharose. Lawler et al. [1], observed that the resistance of 
TSP-4 to tryptic digestion is calcium-dependent. This is consis- 
tent with the selective xtractibility from tendon tissue by the 
use of EDTA-containing buffer, which implies that interactions 
with other matrix components require a calcium-dependent 
structure. The copurification of a prominent fragment of TSP-4 
with an apparent molar mass of about 120 kDa after reduction 
throughout he purification procedure including molecular 
sieve chromatography shows that this fragment still displays a
pentameric structure and is only apparent as a distinct polypep- 
tide after reduction and denaturation. The fact that the N- 
terminal globular domain is missing in the 120 kDa protein 
suggests that this part of the molecule is not essential for retain- 
ing pentameric structure. It is likely that TSP-4, similarily to 
COMP, is assembled via a pentameric ~-helical coiled-coil 
structure [15]. The fragmented TSP-4 molecules as well as 
COMP can be almost quantitatively removed from full-length 
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Fig. 2. Domains of thrombospondins a d identification fthe 120 kDa and 135 kDa polypeptides. The domain structures ofTSP- 1, TSP-4, and COMP 
are shown together with the identification of the 120 kDa and 135 kDa polypeptides by comparison of N-terminal protein sequences. The 135 kDa 
and 120 kDa polypeptides from bovine tendon were shown to correspond to full-length and fragmented TSP-4, respectively. The truncated 120 kDa 
fragment is missing the N-terminal globular domain of TSP-4 which contains the heparin binding site. 
TSP-4 by heparin affinity chromatography demonstrating that 
the heparin binding site of TSP-4 is within the N-terminal 
globular domain, in analogy with TSP-1 [16]. This result also 
implies that proteases degrading TSP-4 preferentially cleave all 
five subunits of a pentameric molecule. Proteolytic leavage of 
the N-terminal heparin binding domains must change the prop- 
erties of the whole pentameric molecule and could well be of 
physiological relevance. 
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